SAMDI Tech, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

SAMDI Tech, Inc. - overview

Established

2011

Location

Chicago, IL, US

Primary Industry

Biotechnology

About

Based in Illinois, US, and founded in 2011, SAMDI Tech, Inc. operates as a drug development company. The company was founded by Milan Mrksich. In 2018, Charles River Laboratories acquired SAMDI Tech, Inc.


As of 2023, the company’s CEO is Emilio Cordova. SAMDI provides an MS (mass spectrometry) platform, which is an HTS (high-throughput screening) platform that offers drug discovery solutions for biochemical and cell-based targets. The products and solutions offered by the company include label-free and beyond label-free assay development; in vitro cell-based assays; SAMDI Profiler® software that produces precise data tables and heat maps; radioactivity assay solutions; and many more.


Current Investors

Charles River Laboratories

Primary Industry

Biotechnology

Sub Industries

Biotechnology, Medical Software, Analytics & Performance Software

Website

www.samditech.com

Verticals

HealthTech

Total Amount Raised

Subscriber access only

SAMDI Tech, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
LP DirectCompletedSAMDI Tech, Inc.-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.